Skip to main content
. 2020 Nov 4;9(22):e016391. doi: 10.1161/JAHA.120.016391

Figure 6. Periprocedural local hydrogen sulfide therapy limits vein graft disease.

Figure 6

GYY indicates hydrogen sulfide prodrug; H2S, hydrogen sulfide; VSMC, vascular smooth muscle cell.